why do they say this is price sensitive ? is it stating any revenue ? it's just a submission and we know RAPs track record on FDA submissions. hopefully they haven't used those expensive consultants who had 90% track record again
Ann: ResApp announces FDA 510(k) submission for SleepCheckRx, page-7
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
Add to My Watchlist
What is My Watchlist?